Kallikrein-related peptidases
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Book |
| Language: | English |
| Published: |
Berlin :
Walter de Gruyter,
c2012.
|
| Subjects: | |
| Online Access: | http://site.ebrary.com/lib/ucy/Doc?id=10649214 |
Table of Contents:
- Genomic structure of the KLK locus
- Single nucleotide polymorphisms in the human KLK locus and their implication in various diseases
- Evolution of Kallikrein-related peptidases
- Structural aspects of Kallikrein-related peptidases
- Molecular recognition properties of Kallikrein-related peptidases on synthetic and endogenous substrates
- Natural, engineered, and synthetic inhibitors of Kallikrein-related peptidases
- Kallikrein-related peptidases as pharmaceutical targets
- Expression of Kallikrein-related peptidases under (patho) physiological conditions
- Kallikrein-related peptidases within the proteolytic web
- Kallikrein-Kinin cascade: bioregulation by human tissue kallikrein 1 (HK1, KLK 1)
- Role of KLK4 in dental enamel formation.
- Kallikrein-related peptidases and semen
- Kallikrein-related peptidases and inhibitors of the skin
- Physiological and pathophysiological roles of Kallikrein-related peptidases in the central nervous system
- Kallikrein-related peptidases (KLKS), proteinase-mediated signaling and proteinase-activated receptors (PARS)
- Pathophysiology of Kallikrein-related peptidases in lung cancer
- Clinical relevance of Kallikrein-related peptidases in gastric and colorectal cancer
- Pathophysiology of Kallikrein-related peptidases in head and neck cancer
- PSA (prostate-specific antigen) and other Kallikrein-related peptidases in prostate cancer
- Cellular model systems to study the tumor biological role of Kallikrein-related peptidases in ovarian and prostate cancer
- Clinical relevance of Kallikrein-related peptidases in breast cancer
- Clinical relevance of Kallikrein-related peptidases in ovarian cancer
- MicroRNAs : a new control mechanism for Kallikrein-related peptidases in kidney and other cancers
- Genomic instability of the KLK-locus in cancer
- Kallikrein-related peptidases as biomarkers in personalized cancer medicine.